| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.17 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.3 |